Abstract:Shenglan Zhu, 1 Junlin Ren, 2 Ling Feng, 1 Yi Jiang 1 1 Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, People's Republic of China; 2 Department of Computer Science, Huazhong University of Science and Technology, Wuhan, 430074, People's Republic of China Correspondence: Yi Jiang; Ling Feng, Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan, Hubei, 430030, People's Republic of China, Email ; Introduction: Previous studies have shown that pregnant women with systemic lupus erythematosus (SLE) tend to have a higher risk of adverse pregnancy outcomes, but the potential causal role remained unclear. In this study, we aimed to investigate the causal relationship between SLE and some common pregnancy complications and outcomes using two-sample Mendelian randomization (MR). Methods: The genetic tools were derived from genome-wide association studies of SLE and pregnancy complications and outcomes. MR analysis was performed using inverse variance weighting as primary method. Sensitivity analyses were performed to evaluate the robustness of the results. A retrospective analysis was conducted on 200 pregnant women with SLE and a control group of pregnant women delivering at Tongji Hospital. Results: In the results, we found that genetic susceptibility to SLE was associated with a higher risk of gestational diabetes mellitus (OR = 1.028, 95% CI: 1.006– 1.050), premature delivery (OR = 1.039, 95% CI: 1.013– 1.066), polyhydramnios (OR = 1.075, 95% CI: 1.004– 1.151) and premature rupture of membranes (OR = 1.030, 95% CI: 1.001– 1.060). Some of the retrospective analysis results align with the findings from the MR analysis, indicating that pregnant women with SLE have a higher risk of developing gestational diabetes mellitus and preterm birth. Additionally, although MR analysis did not reveal a causal relationship between SLE and preeclampsia/eclampsia, retrospective analysis discovered that SLE pregnant women are more susceptible to developing preeclampsia/eclampsia (OR = 2.935, 95% CI: 1.118– 7.620). Conclusion: Our study findings suggest a potential causal relationship between SLE and increased risks of gestational diabetes and preterm delivery. Clinical data indicate that pregnant women with SLE are more prone to developing preeclampsia/eclampsia. Clinicians need to be vigilant about the occurrence of these conditions when managing pregnant women with SLE. Keywords: systemic lupus erythematosus, pregnancy complications, Mendelian randomization, gestational diabetes mellitus, preeclampsia, retrospective analysis Systemic lupus erythematosus (SLE) is a disease characterized by the immune system attacking healthy cells and tissues throughout the body. 1 The global prevalence of SLE is highly variable, ranging from 13 to 7713.5 cases per 100,000 individuals, with significant variations across different populations and regions. The mortality associated with SLE is two to three times higher than that of the general population. 2 Despite its prevalence, the pathogenesis of SLE remains unclear, and a complex interplay of genetic, epigenetic, immunomodulatory, ethnic, hormonal, and environmental factors has been suggested as the primary contributing factors. 3 Women constitute the main affected population by SLE, with the incidence in females approximately 5 times higher than that in males (representing 85–93% of individuals with SLE). The peak incidence occurs earlier, mainly around the age of 30 compared to the age of 50, 4,5 making SLE one of the leading causes of death in young women. 6 Although it is generally believed that fertility in women with SLE is unaffected, disease-related factors, the psychosocial impact of chronic illness, and medication exposure may impair gonadal function. 7 In the context of the ongoing second demographic transition globally, characterized by long-term sub-replacement fertility, 8 the implications of the low fertility rate are crucial for the rapid aging of populations worldwide. 9 The age range of high incidence for female SLE coincides with the reproductive age range, potentially impacting women's reproductive behavior. 10 While pregnancy in women with SLE was historically discouraged due to increased thrombotic risk, multi-organ damage, and consequences of immunosuppressive therapy, advancements in preconception counseling, rigorous monitoring, and improved treatment have enabled most SLE patients to have successful pregnancies. 11 Curr -Abstract Truncated-

Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study

Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis

From Prenatal Counseling to Postpartum Support

Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus

Pregnancy outcomes in patients with systemic lupus erythematosus compared to a high-risk tertiary cohort and to standard population from the Austrian birth registry

Effects of Perinatal Disease Activity on Offspring's Growth in Patients with Systemic Lupus Erythematosus

Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study

OA22 Pregnancy in connective tissue diseases: a 30 year follow-up study of 465 pregnancies from a Spanish monocentric registry

A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus

The Long-Term Developmental Outcomes of Children Born to Mothers with Systemic Lupus Erythematosus at Different Parities

Pregnancy outcomes and risk factors analysis in patients with systemic lupus erythematous

Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study

Effect of remission, clinical remission with active serology, and glucocorticoid dosage on the pregnancy outcome of pregnant patients with systemic lupus erythematosus

Prediction of Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus

Therapeutic changes of systemic lupus erythematosus (SLE) patients in pregnancy and feto-maternal outcomes: a retrospective cohort study

Systemic Lupus Erythematosus and Pregnancy Complications and Outcomes: A Mendelian Randomization Study and Retrospective Validation

The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study

Breastfeeding in women affected by systemic lupus erythematosus: Rate, duration and associated factors

[Maternal and Fetal Outcomes in Systemic Lupus Erythematosus: Analysis of 41 Patients].

High-risk factors for adverse pregnancy outcomes in systemic lupus erythaematosus: a retrospective study of a Chinese population

Active but not quiescent lupus nephritis during pregnancy is associated with a higher rate of adverse obstetric outcomes: Analysis of a prospective cohort